Scientific Compliance Company, a resident of Skolkovo (VEB Group.Russia), opened a new laboratory complex in Moscow, the Center for Scientific Research (CDC) for the study of medicines. The center will perform tests on modern equipment using reagents of its own production based on innovative scientific approaches.
The Central Research Center laboratory complex consists of an analytical laboratory and a production line. The analytical laboratory will test tablets using static and dynamic models of the human gastrointestinal tract. All tests involve mathematical processing and modeling of the data obtained using software. One of the new methods introduced by the analytical laboratory for regulatory and scientific testing is the assessment of the release and permeability of drugs for external use on a vertical diffusion cell.
The main activity of the CNR production line is the manufacture of reagents for scientific testing, one of which is a powder for the preparation of biorelevant dissolution media SC Powder. The reagent makes it possible to reproduce conditions close to various parts of the human gastrointestinal tract, which expands the possibilities of analyzing solid dosage forms and makes it possible to obtain relevant results in combination with dynamic gastrointestinal models that reliably correlate with human trials in clinical trials. It was with this product that the company expanded the number of Skolkovo residents in 2024.
It is important that Scientific Compliance applies scientific approaches in its activities, as well as uses reagents and equipment of its own production. Developments that have already been tested become available for purchase by other companies. Thus, powder for the preparation of biorelevant dissolution media, after successful application in internal scientific activities, is currently being purchased by more than 12 pharmaceutical manufacturers throughout the country.
"The opening of the new laboratory complex will allow the company to increase the number of lines for simultaneous testing, as well as provide an opportunity to expand the range of in vitro drug testing methods. This area is especially relevant as part of an increase in the number of developments of domestic reproduced and original drugs," she said. Alexandra Suvorova, Director of the Scientific Research Center at Scientific Compliance.
Please note that this press release is based on materials provided by the company. AK&M Information Agency shall not be held liable for its contents, nor for the legal and other consequences of its publication.
